Global Cell-Based Assays Market size is expected to be worth around US$ 37.1 Billion by 2032 from US$ 17.7 Billion in 2023, growing at a CAGR of 8.8% ...
Following the earnings announcement, Quest Diagnostics (NYSE:DGX)' stock price rose by 0.48% in pre-market trading. The stock ...